We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SOS:NYSESOS Limited Analysis

Data as of 2026-05-02 - not real-time

$1.19

Latest Price

8/10Risk

Risk Level: High

Executive Summary

SOS Limited trades at an eye‑catching price‑to‑book of 0.02 and a price‑to‑sales of 0.04, suggesting a deep discount relative to its balance sheet, yet the company reports a negative operating margin of –16.7% and a trailing EPS of –2.08, highlighting severe profitability challenges. Revenue surged 48% year‑over‑year, but gross margin is barely 1.3% and cash flow remains heavily negative, underscoring a fragile operating model. Technically, the stock sits below its 50‑day (1.181) and 200‑day (1.812) moving averages, with a bearish trend, while the MACD has turned bullish and the RSI hovers around a neutral 53, indicating mixed short‑term momentum. Volume is decreasing and the 30‑day volatility exceeds 150%, compounded by a beta of ~2.8, pointing to a highly volatile and illiquid security. The recent announcement of a Tier III modular data‑center in Texas provides a tangible growth catalyst, but the capital‑intensive nature of the project adds execution risk. Overall, the juxtaposition of a severely discounted valuation against weak fundamentals, high volatility, and regulatory exposure in China creates a high‑risk, high‑potential profile.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical positioning below key moving averages
  • Decreasing volume and extreme short‑term volatility
  • Negative profitability and cash flow

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth and deep valuation discount
  • Potential upside from new data‑center development
  • Continued regulatory and execution uncertainties

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Massive book‑value discount (PB ~0.02)
  • Opportunity for turnaround if new projects generate cash flow
  • Low price relative to peers in the capital‑markets sub‑sector

Key Metrics & Analysis

Financial Health

Revenue Growth48.10%
Profit Margin-6.49%
ROE-4.09%
ROA-2.64%
P/B Ratio0.0
Op. Cash Flow$-250528992
Free Cash Flow$-250583872
Industry P/E17.5

Technical Analysis

TrendBearish
RSI53.1
Support$0.91
Resistance$1.36
MA 20$1.11
MA 50$1.18
MA 200$1.81
MACDBullish
VolumeDecreasing
Fear & Greed Index91.09

Valuation

GradeUndervalued
TypeBlend

Risk Assessment

Beta2.80
Volatility150.22%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.